Charles Schwab’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80K | Sell |
10,000
-8,868
| -47% | -$70.9K | ﹤0.01% | 3423 |
|
|
2025
Q1 | $184K | Buy |
18,868
+9,996
| +113% | +$97.6K | ﹤0.01% | 3272 |
|
|
2024
Q4 | $112K | Buy |
8,872
+4
| +0% | +$51 | ﹤0.01% | 3389 |
|
|
2024
Q3 | $143K | Sell |
8,868
-17,149
| -66% | -$276K | ﹤0.01% | 3362 |
|
|
2024
Q2 | $635K | Sell |
26,017
-3,440
| -12% | -$83.9K | ﹤0.01% | 3095 |
|
|
2024
Q1 | $2.12M | Buy |
29,457
+152
| +0.5% | +$10.9K | ﹤0.01% | 2574 |
|
|
2023
Q4 | $5.83M | Buy |
29,305
+1,581
| +6% | +$314K | ﹤0.01% | 2242 |
|
|
2023
Q3 | $3.69M | Buy |
27,724
+2,993
| +12% | +$398K | ﹤0.01% | 2390 |
|
|
2023
Q2 | $3.7M | Buy |
24,731
+360
| +1% | +$53.9K | ﹤0.01% | 2353 |
|
|
2023
Q1 | $3.58M | Buy |
24,371
+2,973
| +14% | +$436K | ﹤0.01% | 2347 |
|
|
2022
Q4 | $3.39M | Buy |
21,398
+587
| +3% | +$93K | ﹤0.01% | 2394 |
|
|
2022
Q3 | $4.01M | Buy |
20,811
+1,759
| +9% | +$339K | ﹤0.01% | 2329 |
|
|
2022
Q2 | $2.78M | Buy |
19,052
+825
| +5% | +$120K | ﹤0.01% | 2450 |
|
|
2022
Q1 | $3.21M | Buy |
18,227
+468
| +3% | +$82.3K | ﹤0.01% | 2481 |
|
|
2021
Q4 | $5.22M | Buy |
17,759
+242
| +1% | +$71.1K | ﹤0.01% | 2325 |
|
|
2021
Q3 | $4.35M | Buy |
17,517
+7,422
| +74% | +$1.84M | ﹤0.01% | 2439 |
|
|
2021
Q2 | $2.57M | Buy |
10,095
+1,845
| +22% | +$469K | ﹤0.01% | 2626 |
|
|
2021
Q1 | $1.47M | Sell |
8,250
-43
| -0.5% | -$7.64K | ﹤0.01% | 2731 |
|
|
2020
Q4 | $1.31M | Buy |
8,293
+118
| +1% | +$18.7K | ﹤0.01% | 2699 |
|
|
2020
Q3 | $2.11M | Buy |
8,175
+1,705
| +26% | +$439K | ﹤0.01% | 2477 |
|
|
2020
Q2 | $1.5M | Buy |
6,470
+2,766
| +75% | +$642K | ﹤0.01% | 2513 |
|
|
2020
Q1 | $631K | Buy |
3,704
+1,679
| +83% | +$286K | ﹤0.01% | 2631 |
|
|
2019
Q4 | $448K | Buy |
+2,025
| New | +$448K | ﹤0.01% | 2860 |
|